HIV Archives - ImmunityBio

The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques

Jul 20, 2023 | HIV

Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

Jul 19, 2023 | HIV

Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques

Jul 19, 2023 | HIV

Therapeutic Potential of IL-15 and N-803 in HIV/SIV Infection

Jul 10, 2023 | HIV

Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

Feb 28, 2022 | HIV

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells

Nov 5, 2018 | HIV